Lv71
5010 积分 2023-06-19 加入
Response to “Interpreting bone turnover responses and treatment persistence with once-weekly teriparatide”
1小时前
已关闭
Efficacy of once-weekly teriparatide versus alendronate in Chinese postmenopausal osteoporosis: a randomised, open-label, active-controlled, 48-week, multicentre phase III study
1小时前
已关闭
[Guideline for the diagnosis and treatment of psoriasis arthropathica (psoriatic arthritis) in China (2026 edition)]
1个月前
已完结
Guideline for the diagnosis and treatment of psoriasis in China (2023 edition)
2个月前
已完结
Deucravacitinib in moderate-to-severe plaque psoriasis: a real-world study of effectiveness and safety in clinical practice
2个月前
已完结
Long-Term Experience with Luspatercept in Relapsed/Refractory Myelodysplastic Neoplasms: A Chinese Real-World Study
3个月前
已完结
Luspatercept versus epoetin alfa in erythropoiesis-stimulating agent-naive, transfusion-dependent, lower-risk myelodysplastic syndromes (COMMANDS): primary analysis of a phase 3, open-label, randomised, controlled trial
3个月前
已完结
GS-005 Outcomes by liver function in patients with unresectable hepatocellular carcinoma treated with nivolumab plus ipilimumab vs lenvatinib or sorafenib in the CheckMate 9DWtrial
5个月前
已完结
Overall Survival with Neoadjuvant Nivolumab plus Chemotherapy in Lung Cancer
6个月前
已完结
NTRK Fusion Landscape in 195 Positive Cases of 17 Tumors: A Chinese Multicenter Retrospective Study with Optimized Pan-TRK IHC Screening
6个月前
已完结